Dr. Thomas Lönngren, Strategic Advisor NDA Group and former head of the EMA, has been invited by BioMelbourne Network to present at the CEO lunch forum entitled “A CEOs nightmare – Regulatory and Market access failure, How to get a good sleep?”

This exclusive forum is being held on 2nd February at Norton Rose Fulbright, Melbourne.

Dr. Lönngren will present and discuss the common failures in drug development from a regulatory and market access perspective and how to avoid these failures; best practices for regulatory and market access strategies and discuss with the audience the latest pharma sector hot topics including the Brexit.


Dr. Thomas Lönngren

Strategic Advisor

Read more

Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.